DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Baloxavir marboxilis the generic ingredient in one branded drug marketed by Genentech Inc and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Baloxavir marboxil has ninety-six patent family members in thirty countries.
Two suppliers are listed for this compound.
Recent Clinical Trials for BALOXAVIR MARBOXIL
Identify potential brand extensions & 505(b)(2) entrants
|University of Washington||Phase 4|
Pharmacology for BALOXAVIR MARBOXIL
|Drug Class||Polymerase Acidic Endonuclease Inhibitor |
|Mechanism of Action||Polymerase Acidic Endonuclease Inhibitors |
Synonyms for BALOXAVIR MARBOXIL
|(((12aR)-12-((11S)-7,8-Difluoro-6,11-dihydrodibenzo(b,E)thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12ahexahydro-1H-(1,4)oxazino(3,4-C)pyrido(2,1-F)(1,2,4)triazin-7-yl)oxy)methyl methyl carbonate|
|(((R)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl)oxy)methyl methyl carbonate|
|Baloxavir marboxil (JAN/USAN/INN)|
|Baloxavir marboxil [INN]|
|Carbonic acid, (((12aR)-12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,E)thiepin-11-yl)-3,4,6,8,12,12a-hexahydro-6,8-dioxo-1H-(1,4)oxazino(3,4-C)pyrido(2,1-F)(1,2,4)triazin-7-yl)oxy)methyl methyl ester|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Genentech Inc||XOFLUZA||baloxavir marboxil||TABLET;ORAL||210854-001||Oct 24, 2018||RX||Yes||No||Start Trial||Start Trial||Start Trial|
|Genentech Inc||XOFLUZA||baloxavir marboxil||TABLET;ORAL||210854-001||Oct 24, 2018||RX||Yes||No||Start Trial||Start Trial||Y||Start Trial|
|Genentech Inc||XOFLUZA||baloxavir marboxil||TABLET;ORAL||210854-002||Oct 24, 2018||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.